Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SORAFENIB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | SORAFENIB |
| Key Genes/Proteins | ACSL4, BECN1, BRAF, GPX4, MEK, NRF2 |
| Related Diseases | CANCER, FIBROSIS, GLUTAMATE, HEPATOCELLULAR CARCINOMA |
graph TD
SORAFENIB["SORAFENIB"]
SORAFENIB -->|"activates"| ferroptosis["ferroptosis"]
SORAFENIB -->|"inhibits"| SYSTEM_XC_["SYSTEM XC-"]
SORAFENIB -->|"treats"| Liver_Fibrosis["Liver Fibrosis"]
SORAFENIB -->|"inhibits"| Extracellular_Matrix_Accumulat["Extracellular Matrix Accumulation"]
SORAFENIB -->|"treats"| liver_fibrosis["liver_fibrosis"]
SORAFENIB -->|"upregulates"| IL12A["IL12A"]
SORAFENIB -->|"regulates"| HIF1A["HIF1A"]
SORAFENIB -->|"regulates"| STEM_CELLS["STEM CELLS"]
GPAT3["GPAT3"] -->|"targets"| SORAFENIB
SLC7A11["SLC7A11"] -->|"regulates"| SORAFENIB
NRF2["NRF2"] -->|"regulates"| SORAFENIB
GPX4["GPX4"] -->|"regulates"| SORAFENIB
FERROPTOSIS["FERROPTOSIS"] -->|"regulates"| SORAFENIB
FIBROSIS["FIBROSIS"] -->|"regulates"| SORAFENIB
ACSL4["ACSL4"] -->|"regulates"| SORAFENIB
BECN1["BECN1"] -->|"activates"| SORAFENIB| Target | Relation | Type | Str |
|---|---|---|---|
| Hepatic Stellate Cell Ferroptosis | associated_with | process | 0.95 |
| Liver Fibrosis | treats | disease | 0.90 |
| ferroptosis | activates | pathway | 0.90 |
| SYSTEM XC- | inhibits | protein | 0.90 |
| Extracellular Matrix Accumulation | inhibits | process | 0.85 |
| liver_fibrosis | treats | disease | 0.72 |
| IL12A | upregulates | gene | 0.70 |
| FIBROSIS | treats | disease | 0.65 |
| HIF1A | regulates | protein | 0.64 |
| MELATONIN | associated_with | drug | 0.45 |
| FIBROSIS | associated_with | disease | 0.45 |
| ACSL4 | associated_with | gene | 0.45 |
| BECN1 | associated_with | gene | 0.45 |
| CANCER | associated_with | disease | 0.45 |
| BRAF | associated_with | gene | 0.45 |
| GLUTAMATE | associated_with | phenotype | 0.45 |
| TNF | associated_with | gene | 0.45 |
| STEM CELLS | associated_with | cell_type | 0.45 |
| TRAMETINIB | associated_with | drug | 0.45 |
| VEMURAFENIB | associated_with | drug | 0.45 |
| SLC7A11 | associated_with | gene | 0.45 |
| NRF2 | associated_with | gene | 0.45 |
| GPX4 | associated_with | gene | 0.45 |
| STEM CELLS | regulates | cell_type | 0.35 |
| TNF | inhibits | gene | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GPAT3 | targets | gene | 0.80 |
| STEM CELLS | associated_with | cell_type | 0.45 |
| VEMURAFENIB | associated_with | drug | 0.45 |
| DABRAFENIB | associated_with | drug | 0.45 |
| TRAMETINIB | associated_with | drug | 0.45 |
| N-ACETYLCYSTEINE | associated_with | drug | 0.45 |
| GPX4 | associated_with | gene | 0.45 |
| NRF2 | associated_with | gene | 0.45 |
| SLC7A11 | associated_with | gene | 0.45 |
| ACSL4 | associated_with | gene | 0.45 |
| FIBROSIS | associated_with | disease | 0.45 |
| MELATONIN | associated_with | drug | 0.45 |
| BECN1 | associated_with | gene | 0.45 |
| BRAF | associated_with | gene | 0.45 |
| GLUTAMATE | associated_with | phenotype | 0.45 |
| BRAF | inhibits | gene | 0.35 |
| RAF | inhibits | gene | 0.35 |
| MEK | inhibits | gene | 0.35 |
| SLC7A11 | regulates | gene | 0.35 |
| NRF2 | regulates | gene | 0.35 |
| GPX4 | regulates | gene | 0.35 |
| FERROPTOSIS | regulates | process | 0.35 |
| FIBROSIS | regulates | disease | 0.35 |
| ACSL4 | regulates | gene | 0.35 |
| BECN1 | activates | gene | 0.35 |
| FERROPTOSIS | inhibits | process | 0.35 |
| FIBROSIS | inhibits | disease | 0.35 |
| SLC7A11 | inhibits | gene | 0.35 |
| FIBROSIS | activates | disease | 0.35 |
| FERROPTOSIS | associated_with | process | 0.35 |
| SLC7A11 | activates | gene | 0.35 |
| HEPATOCELLULAR CARCINOMA | activates | disease | 0.35 |
| N-ACETYLCYSTEINE | inhibits | drug | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SORAFENIB in their description or question text
No additional research found